RxDoctor Payments Data

Kenneth Nelson, MD

Family Medicine · Westchester, ILNPI 1700838745

Payments from drug & device makers

$1,081in general payments, 2019–2025

Across 57 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$421
  • Pfizer$133
  • GSK$109
  • Lilly USA, LLC$99
  • AbbVie$79
  • Amgen$74
  • plus $166 from 8 others

What the payments were for

  • Food & beverage$95688%
  • Education$12512%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,081 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$92,950
Medicare patients
217
Services billed
1,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$72,060
EliquisApixaban50$59,800
JanuviaSitagliptin Phosphate27$12,945
Rosuvastatin Calcium300$4,623
SymbicortBudesonide/Formoterol Fumarate13$4,490
VyvanseLisdexamfetamine Dimesylate11$4,375
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide173$2,854
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,736
Arnuity ElliptaFluticasone Furoate12$2,434
Simvastatin236$2,396
Atorvastatin Calcium191$2,248
Tamsulosin Hcl68$1,807
Levothyroxine Sodium173$1,756
Losartan Potassium168$1,652
Omeprazole91$1,451

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$421$72,06069 claims
PfizerEliquis$133$59,80050 claims
MerckJanuvia$41$12,94527 claims
AstraZenecaSymbicort$13$4,49013 claims
GSKArnuity Ellipta$109$2,43412 claims
AbbVieSynthroid$79$1,04722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Westchester

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →